134 related articles for article (PubMed ID: 38127826)
61. Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution's high-risk population.
Meiss AE; Thomas M; Modesitt SC; Ring KL; Atkins KA; Mills AM
Hum Pathol; 2018 Dec; 82():20-31. PubMed ID: 29958926
[TBL] [Abstract][Full Text] [Related]
62. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
Ryu JS; Lee HY; Cho EH; Yoon KA; Kim MK; Joo J; Lee ES; Kang HS; Lee S; Lee DO; Lim MC; Kong SY
Cancer Sci; 2020 Oct; 111(10):3912-3925. PubMed ID: 32761968
[TBL] [Abstract][Full Text] [Related]
63. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
[TBL] [Abstract][Full Text] [Related]
64. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.
Woodward ER; Clifford SC; Astuti D; Affara NA; Maher ER
J Med Genet; 2000 May; 37(5):348-53. PubMed ID: 10807693
[TBL] [Abstract][Full Text] [Related]
65. Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex.
Lerma LA; Schade GR; Tretiakova MS
Hum Pathol; 2021 Oct; 116():1-11. PubMed ID: 34153307
[TBL] [Abstract][Full Text] [Related]
66. Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.
Maranchie JK; Afonso A; Albert PS; Kalyandrug S; Phillips JL; Zhou S; Peterson J; Ghadimi BM; Hurley K; Riss J; Vasselli JR; Ried T; Zbar B; Choyke P; Walther MM; Klausner RD; Linehan WM
Hum Mutat; 2004 Jan; 23(1):40-6. PubMed ID: 14695531
[TBL] [Abstract][Full Text] [Related]
67. Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
Zhong X; Dong Z; Dong H; Li J; Peng Z; Deng L; Zhu X; Sun Y; Lu X; Shen F; Su X; Zhang L; Gu Y; Zheng H
PLoS One; 2016; 11(6):e0156789. PubMed ID: 27257965
[TBL] [Abstract][Full Text] [Related]
68. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine.
You YN; Borras E; Chang K; Price BA; Mork M; Chang GJ; Rodriguez-Bigas MA; Bednarski BK; Meric-Bernstam F; Vilar E
Dis Colon Rectum; 2019 Apr; 62(4):429-437. PubMed ID: 30730459
[TBL] [Abstract][Full Text] [Related]
69. Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients.
Yang J; Li H; Li B; Li W; Guo Q; Hu L; Song Z; Zhou B
Front Oncol; 2021; 11():647598. PubMed ID: 33898318
[TBL] [Abstract][Full Text] [Related]
70. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
[TBL] [Abstract][Full Text] [Related]
71. Identification of novel VHL targets that are associated with the development of renal cell carcinoma.
Abdulrahman M; Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Wiesener MS; Richards FM; Johnson CM; Latif F; Maher ER
Oncogene; 2007 Mar; 26(11):1661-72. PubMed ID: 17001320
[TBL] [Abstract][Full Text] [Related]
72. Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer.
Chen B; Zhang G; Li X; Ren C; Wang Y; Li K; Mok H; Cao L; Wen L; Jia M; Li C; Guo L; Wei G; Lin J; Li Y; Zhang Y; Han-Zhang H; Liu J; Lizaso A; Liao N
Aging (Albany NY); 2020 Feb; 12(4):3140-3155. PubMed ID: 32091409
[TBL] [Abstract][Full Text] [Related]
73. Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing.
Lu E; Hatchell KE; Nielsen SM; Esplin ED; Ouyang K; Nykamp K; Zavoshi S; Li S; Zhang L; Wilde BR; Christofk HR; Boutros PC; Shuch B
Cancer; 2022 Feb; 128(4):675-684. PubMed ID: 34724198
[TBL] [Abstract][Full Text] [Related]
74. Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition.
Kamihara J; Zhou J; LaDuca H; Wassner AJ; Dalton E; Garber JE; Black MH
Cancer Med; 2022 Apr; 11(8):1745-1752. PubMed ID: 35174967
[TBL] [Abstract][Full Text] [Related]
75. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
[TBL] [Abstract][Full Text] [Related]
76. Germline pathogenic variants in 786 neuroblastoma patients.
Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani N; Dymek M; Desai H; Hausler R; ; ; ; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
medRxiv; 2023 Jan; ():. PubMed ID: 36747619
[TBL] [Abstract][Full Text] [Related]
77. Genetic kidney cancer syndromes.
Ho TH; Jonasch E
J Natl Compr Canc Netw; 2014 Sep; 12(9):1347-55. PubMed ID: 25190700
[TBL] [Abstract][Full Text] [Related]
78. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
79. Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.
Sekine Y; Iwasaki Y; Aoi T; Endo M; Hirata M; Kamatani Y; Matsuda K; Sugano K; Yoshida T; Murakami Y; Fukui T; Akamatsu S; Ogawa O; Nakagawa H; Numakura K; Narita S; Habuchi T; Momozawa Y
Hum Mol Genet; 2022 Jun; 31(12):1962-1969. PubMed ID: 35764097
[TBL] [Abstract][Full Text] [Related]
80. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer.
Krepline AN; Geurts JL; Akinola I; Christians KK; Clarke CN; George B; Ritch PS; Khan AH; Hall WA; Erickson BA; Griffin MO; Evans DB; Tsai S
HPB (Oxford); 2020 Dec; 22(12):1745-1752. PubMed ID: 32354656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]